Evidence map›Paper›PMID 33973389›Full record

ArticleArthritis care & research2021

Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID-19 Pandemic in a Community Practice-Based Network.

Michael D George, Maria I Danila, Daniel Watrous, Shanmugapriya Reddy, Jeffrey Alper, Fenglong Xie, W Benjamin Nowell, Joel Kallich, Cassie Clinton, Kenneth G Saag and 1 more

Abstract read
In one paragraph

Article in Arthritis care & research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Michael D GeorgeUniversity of Pennsylvania, Philadelphia.ORCID 0000-0002-0398-2308
Maria I DanilaUniversity of Alabama at Birmingham.ORCID 0000-0001-9246-6200
Daniel WatrousSierra Pacific Arthritis, Visalia, California.
Shanmugapriya ReddySouthwest Florida Rheumatology, Riverview.
Jeffrey AlperMedallion Clinical Research Institute, Naples, Florida.
Fenglong XieUniversity of Alabama at Birmingham.
W Benjamin NowellGlobal Healthy Living Foundation, Upper Nyack, New York.ORCID 0000-0002-4951-6476
Joel KallichMassachusetts College of Pharmacy and Health Sciences University, Boston.
Cassie ClintonUniversity of Alabama at Birmingham.
Kenneth G SaagUniversity of Alabama at Birmingham.ORCID 0000-0001-6189-8078
Jeffrey R CurtisUniversity of Alabama at Birmingham.ORCID 0000-0002-8907-8976

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe effect of the COVID-19 pandemic on community-based rheumatology care and the use of telehealth is unclear. We undertook this study to investigate the impact of the pandemic on rheumatology care delivery in a large community practice-based network.

methodsUsing a community practice-based rheumatologist network, we examined trends in in-person versus telehealth visits versus canceled visits in 3 time periods: pre-COVID-19, COVID-19 transition (6 weeks beginning March 23, 2020), and post-COVID-19 transition (May-August). In the transition period, we compared patients who received in-person care versus telehealth visits versus those who cancelled all visits. We used multivariable logistic regression to identify factors associated with canceled or telehealth visits.

resultsPre-COVID-19, there were 7,075 visits/week among 60,002 unique rheumatology patients cared for by ~300 providers practicing in 92 offices. This number decreased substantially (24.6% reduction) during the COVID-19 transition period for in-person visits but rebounded to pre-COVID-19 levels during the post-COVID-19 transition. There were almost no telehealth visits pre-COVID-19, but telehealth increased substantially during the COVID-19 transition (41.4% of all follow-up visits) and slightly decreased during the post-COVID-19 transition (27.7% of visits). Older age, female sex, Black or Hispanic race/ethnicity, lower socioeconomic status, and rural residence were associated with a greater likelihood of canceling visits. Most factors were also associated with a lower likelihood of having telehealth versus in-office visits. Patients living further from the rheumatologists' office were more likely to use telehealth.

conclusionCOVID-19 led to large disruptions in rheumatology care; these disruptions were only partially offset by increases in telehealth use and disproportionately affected racial/ethnic minorities and patients with lower socioeconomic status. During the COVID-19 era, telehealth continues to be an important part of rheumatology practice, but disparities in access to care exist for some vulnerable groups.

Indexed as

Patient Acceptance of Health CareAdultAgedCommunity Health ServicesCOVID-19Delivery of Health CareFemaleFollow-Up StudiesHumansLongitudinal StudiesMaleMiddle AgedOffice VisitsRheumatologyTelemedicine

Identifiers

PMID33973389
PMCPMC8212120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.